IL116436A
(en)
*
|
1995-12-18 |
2006-12-31 |
Yissum Res Dev Co |
Fc?Á-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES AND
|
IL118570A
(en)
*
|
1996-06-04 |
2007-06-17 |
Shai Yarkoni |
Use of a chimeric protein that includes Met – GnRH in the preparation of a pharmaceutical preparation for the treatment of adenocarcinoma or patocarcinoma
|
US6426075B1
(en)
|
1996-11-06 |
2002-07-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Protease-activatable pseudomonas exotoxin A-like proproteins
|
DK1000163T3
(da)
*
|
1997-07-11 |
2006-02-06 |
Us Gov Health & Human Serv |
Pseudomonas-exotoksin A-lignende kimære immunogener
|
US7314632B1
(en)
*
|
1997-07-11 |
2008-01-01 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Pseudomonas exotoxin A-like chimeric immunogens
|
US20030054012A1
(en)
*
|
2000-05-12 |
2003-03-20 |
Fitzgerald David J. |
Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune response
|
US6699672B1
(en)
|
1997-09-02 |
2004-03-02 |
Insight Biopharmaceuticals Ltd. |
Heparanase specific molecular probes and their use research and medical applications
|
US20040213789A1
(en)
*
|
1997-09-02 |
2004-10-28 |
Oron Yacoby-Zeevi |
Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
|
US20010006630A1
(en)
*
|
1997-09-02 |
2001-07-05 |
Oron Yacoby-Zeevi |
Introducing a biological material into a patient
|
US6177545B1
(en)
*
|
1997-09-02 |
2001-01-23 |
Insight Strategy & Marketing Ltd. |
Heparanase specific molecular probes and their use in research and medical applications
|
US20020088019A1
(en)
*
|
1997-09-02 |
2002-07-04 |
Oron Yacoby-Zeevi |
Methods of and pharmaceutical compositions for improving implantation of embryos
|
US6645490B2
(en)
*
|
1998-03-02 |
2003-11-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities
|
US7045305B1
(en)
|
1998-04-08 |
2006-05-16 |
The Regents Of The University Of California |
Methods and reagents for targeting organic compounds to selected cellular locations
|
AU3487499A
(en)
*
|
1998-04-08 |
1999-10-25 |
Regents Of The University Of California, The |
Methods and reagents for targeting organic compounds to selected cellular locations
|
US6277824B1
(en)
*
|
1998-07-10 |
2001-08-21 |
Adherex Technologies |
Compounds and methods for modulating adhesion molecule function
|
US20030217375A1
(en)
*
|
1998-08-31 |
2003-11-20 |
Eyal Zcharia |
Transgenic animals expressing heparanase and uses thereof
|
WO2000052178A1
(en)
*
|
1999-03-01 |
2000-09-08 |
Insight Strategy & Marketing Ltd. |
Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
|
US20030162733A1
(en)
*
|
2000-11-27 |
2003-08-28 |
Haynes Joel R. |
Nucleic acid adjuvants
|
DE60137969D1
(de)
*
|
2000-12-21 |
2009-04-23 |
Us Gov Health & Human Serv |
Ein chimäres protein das nichttoxische pseudomonas exotoxin a und typ iv pilin sequenzen enthält
|
US20040018203A1
(en)
*
|
2001-06-08 |
2004-01-29 |
Ira Pastan |
Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates
|
ES2342929T3
(es)
|
2001-09-26 |
2010-07-19 |
The Government of the United States of America as represented by the Secretary of Health and Human |
Anticuerpos anti-cd22 con afinidad aumentada por las celulas leucemicas que expresan cd22.
|
US6671189B2
(en)
*
|
2001-11-09 |
2003-12-30 |
Minebea Co., Ltd. |
Power converter having primary and secondary side switches
|
US6908453B2
(en)
*
|
2002-01-15 |
2005-06-21 |
3M Innovative Properties Company |
Microneedle devices and methods of manufacture
|
EP2829283B1
(de)
|
2003-04-30 |
2017-06-07 |
Universität Zürich |
Verfahren zur Behandlung von Krebs unter Verwendung eines Immuntoxins
|
US8206950B2
(en)
*
|
2003-06-09 |
2012-06-26 |
Animal Technology Institute Taiwan |
Fusion antigen used as vaccine and method of making them
|
WO2004108065A2
(en)
*
|
2003-06-09 |
2004-12-16 |
Insight Biopharmaceuticals Ltd. |
Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
|
US7595054B2
(en)
*
|
2003-06-09 |
2009-09-29 |
Healthbanks Biotech Co., Ltd. |
Fusion antigen used as vaccine
|
US7335361B2
(en)
*
|
2003-06-09 |
2008-02-26 |
Animal Technology Institute Taiwan |
Fusion antigen used as vaccine
|
JP4813364B2
(ja)
|
2003-11-25 |
2011-11-09 |
アメリカ合衆国 |
突然変異型抗cd22抗体および免疫複合体
|
US7999077B2
(en)
*
|
2004-09-30 |
2011-08-16 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
IRTA2 antibodies and methods of use
|
US7611714B2
(en)
|
2004-10-04 |
2009-11-03 |
Trinity Biosystems, Inc. |
Methods and compositions for immunizing against Pseudomonas infection
|
US20090155297A1
(en)
*
|
2004-10-04 |
2009-06-18 |
Trinity Biosystems, Inc. |
Methods and Compositions for Inducing an Immune Response Against Multiple Antigens
|
EP1804832A4
(de)
*
|
2004-10-04 |
2008-12-24 |
Trinity Biosystems Inc |
Verfahren und zusammensetzungen zur nadellosen abgabe von makromolekülen
|
WO2006125076A2
(en)
|
2005-05-18 |
2006-11-23 |
Trinity Biosystems, Inc. |
Methods and compositions for immunizing against chlamydia infection
|
CA2941466C
(en)
*
|
2005-07-29 |
2019-12-03 |
The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services |
Mutated pseudomonas exotoxins with reduced antigenicity
|
WO2007067597A2
(en)
*
|
2005-12-05 |
2007-06-14 |
Trinity Biosystems, Inc. |
Methods and compositions for needleless delivery of binding partners
|
CA2631952A1
(en)
*
|
2005-12-05 |
2007-06-14 |
Trinity Biosystems, Inc. |
Methods and compositions for needleless delivery of antibodies
|
EP2010205A2
(de)
|
2006-03-16 |
2009-01-07 |
Trinity Biosystems, Inc. |
Verfahren zur erhöhung der grösse von tieren mit nadellos abgegebenen konstrukten
|
EP2046375B1
(de)
|
2006-07-20 |
2017-04-05 |
The General Hospital Corporation |
Verfahren und zusammensetzungen zur selektiven aktivierung von protoxinen durch kombinatorisches targeting
|
US20090092660A1
(en)
*
|
2006-08-09 |
2009-04-09 |
Trinity Biosystems, Inc. |
Methods and compositions for needleless delivery of particles
|
US8597655B2
(en)
|
2007-05-10 |
2013-12-03 |
Ramot At Tel-Aviv University Ltd. |
Recombinant fusion protein and polynucleotide construct for immunotoxin production
|
US8043621B2
(en)
*
|
2007-05-10 |
2011-10-25 |
Ramot At Tel Aviv University Ltd. |
Recombinant fusion protein and polynucleotide construct for immunotoxin production
|
EP2178559B1
(de)
*
|
2007-07-20 |
2015-06-24 |
The General Hospital Corporation |
Rekombinante vibrio-cholerae-exotoxine
|
WO2009032954A1
(en)
|
2007-09-04 |
2009-03-12 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Deletions in domain ii of pseudomonas exotoxin a that reduce non-specific toxicity
|
CN101983070B
(zh)
*
|
2008-02-20 |
2016-03-30 |
格林考瓦因有限公司 |
由来源于原核细胞的重组n-糖基化蛋白制备生物共轭物
|
WO2010045495A2
(en)
|
2008-10-16 |
2010-04-22 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
|
EP2379720B1
(de)
|
2009-01-20 |
2016-08-17 |
Alona Zilberberg |
Durch den promoter mir-21 angetriebene gezielte krebstherapie
|
WO2011031441A1
(en)
|
2009-08-28 |
2011-03-17 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Therapy with a chimeric molecule and a pro-apoptotic agent
|
CN102655882B
(zh)
|
2009-09-11 |
2014-11-19 |
美国政府健康及人类服务部 |
具有降低的免疫原性的改进的假单胞菌外毒素a
|
WO2011100455A1
(en)
|
2010-02-12 |
2011-08-18 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Inhibition of antibody responses to foreign proteins
|
EP3135692B8
(de)
|
2010-06-16 |
2019-03-20 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Antikörper zu endoplasmin und deren verwendung
|
PL3434346T3
(pl)
|
2010-07-30 |
2021-04-06 |
Medimmune, Llc |
Oczyszczone aktywne polipeptydy lub immunokoniugaty
|
US11246915B2
(en)
|
2010-09-15 |
2022-02-15 |
Applied Molecular Transport Inc. |
Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
|
EP2616045B1
(de)
|
2010-09-15 |
2017-10-25 |
Randall J. Mrsny |
Systeme und verfahren zur abgabe bioaktiver mittel unter verwendung von aus bakteriellem toxin gewonnenen transportsequenzen
|
US8771687B2
(en)
|
2010-12-02 |
2014-07-08 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Methods for treating a tumor using an antibody that specifically binds GRP94
|
EP2699603B1
(de)
|
2011-04-19 |
2016-03-02 |
The United States of America As Represented by the Secretary Department of Health and Human Services |
Für glypican-3 spezifische humane monoklonale antikörper und ihre verwendung
|
PE20141454A1
(es)
|
2011-05-06 |
2014-10-23 |
Us Gov Health & Human Serv |
Inmunotoxina recombinante dirigida a la mesotelina
|
AU2012268013B2
(en)
|
2011-06-09 |
2016-11-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes
|
US8932586B2
(en)
|
2011-09-06 |
2015-01-13 |
Intrexon Corporation |
Modified forms of Pseudomonas exotoxin A
|
WO2013039916A1
(en)
|
2011-09-12 |
2013-03-21 |
The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services |
Compositions for and methods of treatment and enhanced detection of non-pituitary tumors
|
WO2013040141A1
(en)
|
2011-09-16 |
2013-03-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Pseudomonas exotoxin a with less immunogenic b cell epitopes
|
US20140234360A1
(en)
|
2011-09-30 |
2014-08-21 |
The United States of America, as represented by the Secretary, Dept.of Health and Human Services |
Influenza vaccine
|
EP2764025B1
(de)
|
2011-10-04 |
2017-11-29 |
IGEM Therapeutics Limited |
Ige-antikörper gegen hmw-maa
|
SG11201407972RA
(en)
|
2012-06-01 |
2015-01-29 |
Us Health |
High-affinity monoclonal antibodies to glypican-3 and use thereof
|
WO2014031476A1
(en)
|
2012-08-21 |
2014-02-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin domain-specific monoclonal antibodies and use thereof
|
US9416190B2
(en)
|
2012-09-27 |
2016-08-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin antibodies and methods for eliciting potent antitumor activity
|
WO2014100443A2
(en)
|
2012-12-20 |
2014-06-26 |
Medimmune, Llc |
Methods of producing immunoconjugates
|
US9790282B2
(en)
|
2013-03-25 |
2017-10-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-CD276 polypeptides, proteins, and chimeric antigen receptors
|
CA2926215A1
(en)
|
2013-10-06 |
2015-04-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Modified pseudomonas exotoxin a
|
ES2764833T3
(es)
|
2013-10-11 |
2020-06-04 |
The United States Of America Represented By The Sec Dep Of Health And Human Services |
Anticuerpos contra TEM8 y su uso
|
US20160280798A1
(en)
|
2013-11-06 |
2016-09-29 |
The United States Of America, As Represented By The Secretary Department Of Health & Human Service |
Alk antibodies, conjugates, and chimeric antigen receptors, and their use
|
WO2015120058A2
(en)
|
2014-02-05 |
2015-08-13 |
Molecular Templates, Inc. |
Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity
|
MA39776A
(fr)
|
2014-03-24 |
2017-02-01 |
Hoffmann La Roche |
Traitement du cancer avec des antagonistes de c-met et corrélation de ces derniers avec l'expression de hgf
|
AU2015255834B2
(en)
|
2014-05-07 |
2020-05-21 |
Applied Molecular Transport Llc |
Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
|
CN106999578B
(zh)
|
2014-07-31 |
2022-03-04 |
美国政府(由卫生和人类服务部的部长所代表) |
针对epha4的人类单克隆抗体和其用途
|
JP6613304B2
(ja)
|
2014-09-17 |
2019-12-04 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
抗cd276抗体(b7h3)
|
WO2016146833A1
(en)
|
2015-03-19 |
2016-09-22 |
F. Hoffmann-La Roche Ag |
Biomarkers for nad(+)-diphthamide adp ribosyltransferase resistance
|
EP3184547A1
(de)
|
2015-10-29 |
2017-06-28 |
F. Hoffmann-La Roche AG |
Anti-tpbg-antikörper und verfahren zur verwendung
|
WO2017077367A1
(en)
|
2015-11-06 |
2017-05-11 |
Uniwersytet Warszawski |
Purification method for recombinant exotoxin a, recombinant exotoxin a muteins and recombinant proteins comprising exotoxin a fragments
|
EP3374396A1
(de)
|
2015-11-13 |
2018-09-19 |
The United States of America, as represented by the secretary, Department of Health and Human Services |
Anti-bcma-polypeptide und proteine
|
WO2017196847A1
(en)
|
2016-05-10 |
2017-11-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Variable new antigen receptor (vnar) antibodies and antibody conjugates targeting tumor and viral antigens
|
WO2017214182A1
(en)
|
2016-06-07 |
2017-12-14 |
The United States Of America. As Represented By The Secretary, Department Of Health & Human Services |
Fully human antibody targeting pdi for cancer immunotherapy
|
CA3031559A1
(en)
|
2016-08-02 |
2018-02-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Monoclonal antibodies targeting glypican-2 (gpc2) and use thereof
|
EP3518968B1
(de)
|
2016-10-03 |
2022-01-05 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Hiv-1-env-fusionspeptid-immunogene und deren verwendung
|
WO2018081832A1
(en)
|
2016-10-31 |
2018-05-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Peptide fragments from filoviruses and their uses
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
WO2018119279A1
(en)
|
2016-12-21 |
2018-06-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies specific for flt3 and uses thereof
|
WO2018176031A1
(en)
|
2017-03-24 |
2018-09-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Glycan-masked engineered outer domains of hiv-1 gp120 and their use
|
US11390683B2
(en)
|
2017-05-18 |
2022-07-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin polypeptides and proteins
|
CA3059472A1
(en)
|
2017-05-19 |
2018-11-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibody targeting tnfr2 for cancer immunotherapy
|
WO2019005208A1
(en)
|
2017-06-30 |
2019-01-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
ANTIBODIES TO HUMAN MESOTHELIN AND USES IN ANTICANCER THERAPY
|
WO2019006280A1
(en)
|
2017-06-30 |
2019-01-03 |
Lentigen Technology, Inc. |
HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO CD33 AND METHODS OF USE
|
WO2019051204A1
(en)
|
2017-09-08 |
2019-03-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
SYNERGISTIC COMBINATION OF IL4, INTERFERON GAMMA AND INTERFERON ALPHA RECEPTOR AGENTS FOR USE IN THE TREATMENT OF OVARIAN CANCER
|
US11795235B2
(en)
|
2017-09-18 |
2023-10-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Immunotoxins with albumin binding domain
|
US11136356B2
(en)
|
2017-10-16 |
2021-10-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant HIV-1 envelope proteins and their use
|
CN112105376A
(zh)
|
2018-03-08 |
2020-12-18 |
应用分子运输公司 |
用于经口递送的毒素衍生的递送构建体
|
AU2019301675A1
(en)
|
2018-07-12 |
2021-01-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Affinity matured CD22-specific monoclonal antibody and uses thereof
|
CA3106544A1
(en)
|
2018-08-08 |
2020-02-13 |
Mitchell Ho |
High affinity monoclonal antibodies targeting glypican-2 and uses thereof
|
US20210353740A1
(en)
|
2018-09-23 |
2021-11-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic |
Hiv-1 env fusion peptide nanoparticle carrier conjugates and their use
|
WO2020086483A1
(en)
|
2018-10-22 |
2020-04-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant gp120 protein with v1-loop deletion
|
SG11202104734YA
(en)
|
2018-11-07 |
2021-06-29 |
Applied Molecular Transport Inc |
Cholix-derived carriers for oral delivery of heterologous payload
|
US20220064324A1
(en)
|
2019-01-08 |
2022-03-03 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Cross species single domain antibodies targeting mesothelin for treating solid tumors
|
CN113784987A
(zh)
|
2019-01-22 |
2021-12-10 |
美国政府(由卫生和人类服务部的部长所代表) |
靶向磷脂酰肌醇蛋白聚糖-1的高亲和力单克隆抗体和使用方法
|
WO2021003297A1
(en)
|
2019-07-02 |
2021-01-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Monoclonal antibodies that bind egfrviii and their use
|
BR112022002962A2
(pt)
|
2019-08-16 |
2022-07-05 |
Applied Molecular Transport Inc |
Composições, formulações e produção e purificação de interleucina
|
CN114729041A
(zh)
|
2019-10-22 |
2022-07-08 |
美国政府(由卫生和人类服务部的部长所代表) |
用于治疗多种实体瘤的靶向b7h3(cd276)的高亲和力纳米抗体
|
WO2021097289A1
(en)
|
2019-11-15 |
2021-05-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Pegylated recombinant immunotoxins
|
WO2021173674A1
(en)
|
2020-02-26 |
2021-09-02 |
A2 Biotherapeutics, Inc. |
Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
|
US20230391852A1
(en)
|
2020-10-26 |
2023-12-07 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting sars coronavirus spike protein and uses thereof
|
US20240075158A1
(en)
|
2020-12-22 |
2024-03-07 |
Jiangsu Hengrui Pharmaceutical Co., Ltd. |
Complex of anti-il-4r antibody or antigen-binding fragment thereof and medical use thereof
|
WO2022232612A1
(en)
|
2021-04-29 |
2022-11-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Lassa virus-specific nanobodies and methods of their use
|
CN117500831A
(zh)
|
2021-06-09 |
2024-02-02 |
美国政府(由卫生和人类服务部的部长所代表) |
用于治疗实体瘤的靶向pd-l1的跨物种单结构域抗体
|
AU2022323509A1
(en)
|
2021-08-03 |
2024-02-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hiv-1 vaccination and samt-247 microbicide to prevent hiv-1 infection
|
WO2023076881A1
(en)
|
2021-10-26 |
2023-05-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting the s2 subunit of sars-cov-2 spike protein
|
AU2022416639A1
(en)
|
2021-12-17 |
2024-07-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin polypeptides, proteins, and chimeric antigen receptors
|
WO2023192835A1
(en)
|
2022-03-27 |
2023-10-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Base-covered hiv-1 envelope ectodomains and their use
|
WO2024050399A1
(en)
|
2022-09-01 |
2024-03-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting hpv e6/e7 oncogenic peptide/mhc complexes
|
WO2024104584A1
(en)
|
2022-11-17 |
2024-05-23 |
University Of Cape Town |
Deimmunized pseudomonas exotoxin a
|